Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short Course vs Standard Treatment in Chronic Hepatitis C
NCT00502970Phase 4Completed
- Sponsor
- Aga Khan University
- Start
- May 2004
- Primary completion
- Nov 2007
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of interferon alfa-2a, ribavirin in hepatitis C (HCV), sponsored by Aga Khan University. Started May 2004; status: completed.
02
Drugs
interferon alfa-2aribavirin
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00502970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00502970.